Dr. Kehl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Boston, MA 02215Phone+1 312-695-9797- Is this information wrong?
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
- Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
- Northwestern University The Feinberg School of MedicineClass of 2008
Certifications & Licensure
- MA State Medical License 2012 - 2024
- TX State Medical License 2014 - 2019
- IL State Medical License 2010 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Perspectives of Oncologists on the Ethical Implications of Using Artificial Intelligence for Cancer Care.Thomas P Walsh, Richard Sharp, Eliezer Van Allen, Andrew Hantel, Jonathan M Marron, Kenneth L Kehl, Gregory A Abel> ;JAMA Network Open. 2024 Mar 4
- Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data Set.Kenneth L Kehl, Jessica A Lavery, Samantha Brown, Hannah Fuchs, Gregory Riely, Deborah Schrag, Ashley Newcomb, Chelsea Nichols, Christine M Micheel, Philippe L Bedard,...> ;JCO Precision Oncology. 2024 Mar 1
- Identifying Oncology Clinical Trial Candidates Using Artificial Intelligence Predictions of Treatment Change: A Pilot Implementation Study.Tali Mazor, Pavel Trukhanov, James Lindsay, Matthew R Galvin, Karim S Farhat, Emily McClure, Ethan Cerami, Kenneth L Kehl, Antonio Giordano, Leena Gandhi, Deborah Schr...> ;JCO Precision Oncology. 2024 Mar 1
- Join now to see all
Press Mentions
- Computer Platform Helps Match Patients with Cancer to Trials of Targeted TherapyOctober 12th, 2022
- Lack of Guideline-Concordant Treatment for Early-Stage Non-Small Cell Lung Cancer CommonMay 13th, 2022
- ‘More Effort Needed’ to Optimize Use of Standard Early NSCLC TherapiesMarch 22nd, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: